These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 24807349)

  • 1. Chromatin barcodes as biomarkers for melanoma.
    Bastonini E; Jeznach M; Field M; Juszczyk K; Corfield E; Dezfouli M; Ahmat N; Smith A; Womersley H; Jordan P; Ramadass A; Akoulitchev A; Goding CR
    Pigment Cell Melanoma Res; 2014 Sep; 27(5):788-800. PubMed ID: 24807349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A pilot study of chromosomal aberrations and epigenetic changes in peripheral blood samples to identify patients with melanoma.
    Jakub JW; Grotz TE; Jordan P; Hunter E; Pittelkow M; Ramadass A; Akoulitchev A; Markovic S
    Melanoma Res; 2015 Oct; 25(5):406-11. PubMed ID: 26225582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of MITF and other melanosome-related proteins with chemoresistance in melanoma tumors and cell lines.
    Hertzman Johansson C; Azimi A; Frostvik Stolt M; Shojaee S; Wiberg H; Grafström E; Hansson J; Egyházi Brage S
    Melanoma Res; 2013 Oct; 23(5):360-5. PubMed ID: 23921446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Melanoma biomarker expression in melanocytic tumor progression: a tissue microarray study.
    Nazarian RM; Prieto VG; Elder DE; Duncan LM
    J Cutan Pathol; 2010 Apr; 37 Suppl 1():41-7. PubMed ID: 20482674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA regulation of melanoma progression.
    Bonazzi VF; Stark MS; Hayward NK
    Melanoma Res; 2012 Apr; 22(2):101-13. PubMed ID: 22209751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor necrosis factor receptor superfamily member TROY is a novel melanoma biomarker and potential therapeutic target.
    Spanjaard RA; Whren KM; Graves C; Bhawan J
    Int J Cancer; 2007 Mar; 120(6):1304-10. PubMed ID: 17187358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating biomarkers in malignant melanoma.
    Alegre E; Sammamed M; Fernández-Landázuri S; Zubiri L; González Á
    Adv Clin Chem; 2015; 69():47-89. PubMed ID: 25934359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microphthalmia-Associated Transcription Factor: A Central Regulator of Pigment Epithelium-Derived Factor Controlling Human Melanoma Progression.
    Jiménez Cuenca B; Fernández-Barral A; Orgaz JL
    Am J Pathol; 2015 Jul; 185(7):2069-70. PubMed ID: 26093986
    [No Abstract]   [Full Text] [Related]  

  • 9. Global repression of cancer gene expression in a zebrafish model of melanoma is linked to epigenetic regulation.
    Anelli V; Santoriello C; Distel M; Köster RW; Ciccarelli FD; Mione M
    Zebrafish; 2009 Dec; 6(4):417-24. PubMed ID: 20047469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emerging Biomarkers in Cutaneous Melanoma.
    Eisenstein A; Gonzalez EC; Raghunathan R; Xu X; Wu M; McLean EO; McGee J; Ryu B; Alani RM
    Mol Diagn Ther; 2018 Apr; 22(2):203-218. PubMed ID: 29411301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-mediated regulation of melanoma.
    Sun V; Zhou WB; Majid S; Kashani-Sabet M; Dar AA
    Br J Dermatol; 2014 Aug; 171(2):234-41. PubMed ID: 24665835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigating the utility of human melanoma cell lines as tumour models.
    Vincent KM; Postovit LM
    Oncotarget; 2017 Feb; 8(6):10498-10509. PubMed ID: 28060736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biomarker utility of circulating tumor cells in metastatic cutaneous melanoma.
    Khoja L; Lorigan P; Zhou C; Lancashire M; Booth J; Cummings J; Califano R; Clack G; Hughes A; Dive C
    J Invest Dermatol; 2013 Jun; 133(6):1582-90. PubMed ID: 23223143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitf regulation of Dia1 controls melanoma proliferation and invasiveness.
    Carreira S; Goodall J; Denat L; Rodriguez M; Nuciforo P; Hoek KS; Testori A; Larue L; Goding CR
    Genes Dev; 2006 Dec; 20(24):3426-39. PubMed ID: 17182868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical use of p-proteasome in discriminating metastatic melanoma patients: comparative study with LDH, MIA and S100B protein.
    Henry L; Fabre C; Guiraud I; Bastide S; Fabbro-Peray P; Martinez J; Lavabre-Bertrand T; Meunier L; Stoebner PE
    Int J Cancer; 2013 Jul; 133(1):142-8. PubMed ID: 23238767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinction of melanoma in situ from solar lentigo on sun-damaged skin using morphometrics and MITF immunohistochemistry.
    Black WH; Thareja SK; Blake BP; Chen R; Cherpelis BS; Glass LF
    Am J Dermatopathol; 2011 Aug; 33(6):573-8. PubMed ID: 21697700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prognostic role of detection of circulating melanoma cells in the blood.
    Dutcher JP
    J Clin Oncol; 2003 Mar; 21(5):757-9. PubMed ID: 12610168
    [No Abstract]   [Full Text] [Related]  

  • 18. Mitf is the key molecular switch between mouse or human melanoma initiating cells and their differentiated progeny.
    Cheli Y; Giuliano S; Botton T; Rocchi S; Hofman V; Hofman P; Bahadoran P; Bertolotto C; Ballotti R
    Oncogene; 2011 May; 30(20):2307-18. PubMed ID: 21278797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Essential role of microphthalmia transcription factor for DNA replication, mitosis and genomic stability in melanoma.
    Strub T; Giuliano S; Ye T; Bonet C; Keime C; Kobi D; Le Gras S; Cormont M; Ballotti R; Bertolotto C; Davidson I
    Oncogene; 2011 May; 30(20):2319-32. PubMed ID: 21258399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The contribution of proteomics to the identification of biomarkers for cutaneous malignant melanoma.
    Bougnoux AC; Solassol J
    Clin Biochem; 2013 Apr; 46(6):518-23. PubMed ID: 23262402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.